Methyl iodide → 3-(2-aminopyrimidin-4-yl)-5-bromo-1-methyl-2,3-dihydro-1H-1,3-benzodiazol-2-one

HRID 1398639ノート

反応式

HRID 1398639 の反応式
[NH2:1][C:2]1[N:7]=[C:6]([N:8]2[C:12]3[CH:13]=[C:14]([Br:17])[CH:15]=[CH:16][C:11]=3[NH:10][C:9]2=[O:18])[CH:5]=[CH:4][N:3]=1.[H-].[Na+].I[CH3:22]>CN(C=O)C>[NH2:1][C:2]1[N:7]=[C:6]([N:8]2[C:12]3[CH:13]=[C:14]([Br:17])[CH:15]=[CH:16][C:11]=3[N:10]([CH3:22])[C:9]2=[O:18])[CH:5]=[CH:4][N:3]=1

参加物

5

実験手順

To a solution of 1-(2-aminopyrimidin-4-yl)-6-bromo-2,3-dihydro-1H-1,3-benzodiazol-2-one (500 mg, 1.63 mmol) in DMF (10 ml) at 0° C. was added sodium hydride (60% oil suspension, 65.33 g, 1.63 mmol). The reaction mixture was allowed to warm to RT over 5 minutes before addition of iodomethane (0.1 ml, 1.63 mmol) and stirring for 30 minutes. The mixture was quenched by addition of water (5 mL), EtOAc was then added resulting in formation of a precipitate. The precipitate was collected by suction filtration. The filtrate was extracted with EtOAc (×2). The combined organic fractions were washed with water and dried (Na2SO4), filtered and concentrated in vacuo. Combining the extract residue and the precipitate gave the crude title compound (600 mg); 1H NMR (500 MHz, CDCl3) delta 3.23 (3H, s), 5.55 (2H, s), 6.72 (1H, d, J=8.3 Hz), 7.20-7.04 (1H, m), 7.42 (1H, d, J=5.7 Hz), 8.12 (1H, d, J=5.7 Hz), 8.39 (1H, d, J=1.8 Hz); LC-MS: m/z=+321.8 (M+H)+.

後処理

  1. customThe mixture was quenched by addition of water (5 mL), EtOAc
  2. additionwas then added
  3. customresulting in formation of a precipitate
  4. filtrationThe precipitate was collected by suction filtration
  5. extractionThe filtrate was extracted with EtOAc (×2)
  6. washThe combined organic fractions were washed with water
  7. dry with materialdried (Na2SO4)
  8. filtrationfiltered
  9. concentrationconcentrated in vacuo

出典と根拠

ORDレコード
ord-ea79f433d2044506b5ca791b429ac9b9
出典データセット
uspto-grants-2014_12
特許番号
US08901313B2

反応ノート

読み込み中…